Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus
infection in mice models of disease.
Not exact matches
These findings allowed researchers to create a chimera virus: a
mouse virus with a human viral gene that can be used to test molecules that inhibit human LANA protein
in an animal
model of disease, treating not only human herpes virus
infection but also its associated cancers.
In mouse models of disease, Yale researchers looked at the effects
of providing nutrients during
infection and found opposing effects depending on whether the
infections were bacterial or viral.
They show that this new formulation reduces the minimal curative dose
in a
disease model, based on
infections in mice, by 100-fold and, most importantly, circumvents drug resistance
in a cell line that is resistant as a result
of mutations
in the transporter that mediates drug uptake.
Using a
model of Parkinson's
disease in which the toxin MPTP, made famous
in book «The Case
of the Frozen Addicts,» induces Parkinson's - like symptoms
in humans and
mice, Dr. Smeyne showed that
mice infected with H1N1, even long after the initial
infection, had more severe Parkinson's symptoms than those who had not been infected with the flu.
D.K.V. Kumar et al., «Amyloid - β peptide protects against microbial
infection in mouse and worm
models of Alzheimer's
disease,» Science Translational Medicine, doi: 10.1126 / scitranslmed.aaf1059, 2016.
Working with Dr. Weiskopf, we established a
model of human dengue
disease using HLA transgenic
mouse strains, and characterized human dengue - specific CD8 + and CD4 + T - cell responses
in natural
infection as well as following vaccination.